[1]
M. Campanini and G. Mathieu, “Cardiovascular risk and inhibition of cyclooxygenase: traditional nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors”, Ital J Med, vol. 1, no. 1, pp. 37–54, May 2013.